Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06689189 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Detection of Sepsis Occurrence by Using Blood Fluorescence

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 14, 2024 (before its estimated October 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
This study adopted a case-control study method to explore a reagent-free, highly sensitive, and frequently screened blood fluorescence metabolite analyzer for sepsis, which can detect the emergence of inflammatory free radicals before organ damage and shorten the diagnosis time of sepsis.
Trial Details
NCT Number NCT06689189
Lead Sponsor Ningbo Medical Center Lihuili Hospital
Collaborators: University of Macau
Conditions
(from sponsor)		 Sepsis, Organ Damage
Related terms Sepsis
Enrollment 800 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov